Company page

Intellia Therapeutics, Inc.

Intellia Therapeutics, Inc. is a public biotechnology company based in the United States, focused on developing innovative gene editing therapies. The company operates under the ticker NTLA and has a market capitalization of approximately $1.5 billion. Intellia is dedicated to advancing its research and development efforts in the field of genetic medicine.